AR Expression in Breast Cancer CTCs Associates with Bone Metastases
Nicola Aceto(University of Basel), Shyamala Maheswaran(Massachusetts General Hospital), David T. Ting(Massachusetts General Hospital), Francesca Bersani(Ospedale San Luigi Gonzaga), Beverly Moy(Massachusetts General Hospital), Ravi Kapur(Harvard University), Dennis C. Sgroi(Harvard University), Aditya Bardia(UCLA Health), Amanda Engstrom(Harvard University), Daniel A. Haber(Howard Hughes Medical Institute), Maria Donaldson Collier(The Netherlands Cancer Institute), Kira Niederhoffer(Harvard University), Ben S. Wittner(Broad Institute), Olivia Mackenzie(Harvard University), Mehmet Toner(Shriners Hospitals for Children - Erie), Valentine Comaills(Harvard University), Yu Zheng(Howard Hughes Medical Institute), Huili Zhu(Yantai University), Toshi Shioda(Center for Cancer Research), Sridhar Ramaswamy(Harvard University), Ryan OʼKeefe(Harvard University)
Cited by 109
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
|Endocrine Reviews|2012|3.1k